dualCAR-NK19/70
/ Zhejiang University
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
May 06, 2023
Study of Cord Blood-derived CAR NK Cells Targeting CD19/CD70 in Refractory/Relapsed B-cell Non-Hodgkin Lymphoma
(clinicaltrials.gov)
- P1/2 | N=48 | Recruiting | Sponsor: Aibin Liang，MD，Ph.D.
New P1/2 trial • Follicular Lymphoma • Hematological Malignancies • Lymphoma • Mantle Cell Lymphoma • Non-Hodgkin’s Lymphoma • Oncology • CD19 • CD70
February 06, 2023
Clinical Study of Cord Blood-derived CAR NK Cells Targeting CD19/CD70 in Refractory/Relapsed B-cell Non-Hodgkin Lymphoma
(clinicaltrials.gov)
- P1 | N=48 | Recruiting | Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Not yet recruiting ➔ Recruiting
Enrollment open • Follicular Lymphoma • Hematological Malignancies • Lymphoma • Mantle Cell Lymphoma • Non-Hodgkin’s Lymphoma • Oncology • CD19 • CD20
December 28, 2022
Clinical Study of Cord Blood-derived CAR NK Cells Targeting CD19/CD70 in Refractory/Relapsed B-cell Non-Hodgkin Lymphoma
(clinicaltrials.gov)
- P1 | N=48 | Not yet recruiting | Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University
New P1 trial • Follicular Lymphoma • Hematological Malignancies • Lymphoma • Mantle Cell Lymphoma • Non-Hodgkin’s Lymphoma • Oncology • CD19 • CD20
1 to 3
Of
3
Go to page
1